1 / 12

EPF Value+ conference, Gothenburg - 9 December 2009

Patient involvement in FP7 funded research. Stéphane Hogan Head of Coordination unit Directorate Health DG Research European Commission. EPF Value+ conference, Gothenburg - 9 December 2009. Collaborative research in the Health theme. Main policy drivers:

maik
Download Presentation

EPF Value+ conference, Gothenburg - 9 December 2009

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Patient involvement in FP7 funded research Stéphane Hogan Head of Coordination unit Directorate Health DG Research European Commission EPF Value+ conference, Gothenburg - 9 December 2009

  2. Collaborative researchin the Health theme Main policy drivers: • Improving health of European citizens • Increasing competitiveness of health-related industries and businesses • Addressing global health issues, including emerging epidemics Budget: €6.1 billion over 7 years (2007-2013)

  3. Collaborative research across borders and other barriers • betweencountries: • multinational consortia, with at least 3 partners from 27 EU Member States (MS) + 12 Associated Countries (AC)i.e. Albania, Bosnia-Herzegovina, Croatia, FYROM, Iceland, Israel, Liechtenstein, Montenegro, Norway, Serbia, Switzerland, Turkey. • researchers from any country in the world can participate, from industrialised countries and from developing countries. • betweendifferent types oforganizationsPublic sector, private sector & civil society: universities, research centres, industry (including SMEs), patient organisations, other stakeholders… • betweendisciplines: multidisciplinary, translational R&D

  4. The Health ThemeThree main activities (“pillars”) Activity 1: Biotechnology, generic tools & technologies for health Activity 2: Translating research for human health Activity 3: Optimising the delivery of health care The Innovative Medicines Initiative cross-cutting issues:international cooperation, SMEs, child health, ageing populations, gender-related health issues Activity 4:Support actions & response to policy needs

  5. Scope of researchin the Health Theme • Funding can support both basic and applied research including discovery activities, translational research and early clinical trials. Normally phase I and II clinical trials, in some exceptional cases, phase III can included.

  6. Outcome of first calls (2007-2008-2009): 433 projects selected, €1.84 billion awarded plus IMI: 15 projects, €110 million awarded

  7. FP7 projects Focus on patient involvement: • Patientpartner Identifying the needs for Patients Partnering in Clinical ResearchEU grant: €900,000 (36 months)Led by Dutch Genetic Alliance, with Genetic Interest Group, European Genetic Alliances’ Network, European Forum for Good Clinical Practice. • RESPECT Relating Expectations and needs to Participation and Empowerment of children in Clinical TrialsEU grant: €500,000 (36 months)Led by Götheborgs universitet, with EPF, GCPA - Europe, … • CHD PLATFORM Establishment of a European Parent- and Patient-oriented information and communication platform on congenital heart defects.EU grant: €745,000 (24 months) Led by the National Registry for Congenital Heart Defects (DE)

  8. FP7 projects Involving patient representatives in research eg: adapting off-patent medicines to the needs of paediatric populations • EPOC European Paediatric Oncology Off-patent Medicines ConsortiumEU grant: €2,000,000 (48 months)Led by University of Newcastle (UK), 15 partners including the International Confederation of Childhood Cancer Parent Organisations. • 03K Off-patent Oncology Drugs for Kids EU grant: €4,600,000 (36 months)Led by Institut Gustave Roussy (FR), 9 partnersincludingUnion Nationale des Association de Parents d’Enfants atteints de Cancer ou de Leucémie (FR).

  9. Current calls / new initiatives

  10. 2010 calls for proposals • Two main calls: • FP7-HEALTH-2010-single-stage (40 topics) deadline: 19 Nov. 2009 • FP7-HEALTH-2010-two-stage (13 topics) deadline: 29 Oct. 2009 • plus special calls: • FP7-Influenza-2010 (with Food theme)1 topic, deadline: 29 Oct. 2009 • FP7-AFRICA-2010 (with Food and Environment themes)6 topics, deadline: 14 Jan. 2010 • FP7-ERANET-2010-RTD 3 topics, deadline: 19 Jan. 2010 • FP7-HEALTH-2010-alternative-testing 7 topics, deadline: 3 Feb. 2010 • 2nd IMI call, 9 topics, deadline: 8 Feb. 2010 CLOSED CLOSED

  11. Strategy for Health theme in next calls (2011-2012-2013) • Increased focus on fewer areas • to increase critical mass, impact and visibility • therefore, more areas closed in each call • Main thematic priorities for WP 2011: - the brain (neurodegenerative diseases; lifestyle-related aspects); diabetes/obesity & lifestyle-induced conditions; antimicrobial resistance; heath inequalities… • Cross-cutting priorities: SMEs,clinical trials • International cooperation continues to be a policy priority

  12. THANK YOU Stéphane Hogan, Head of Coordination Unit, Health Research, DG Research, European Commission stephane.hogan@ec.europa.eu FP7 Health:http://cordis.europa.eu/fp7/health

More Related